array(3) { ["company_details"]=> array(13) { ["name"]=> string(24) "Idexx Laboratories, Inc." ["slug"]=> string(31) "52dfe-us-idexx-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62" ["description"]=> string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities." ["address_street"]=> string(10) "1 Idexx Dr" ["address_place"]=> string(9) "Westbrook" ["address_region"]=> string(5) "Maine" ["founding_date"]=> string(10) "1983-02-28" ["website_domain"]=> string(9) "idexx.com" ["website_url"]=> string(21) "https://www.idexx.com" ["industry_codes"]=> array(4) { [0]=> string(43) "General Livestock, Except Dairy and Poultry" [1]=> string(33) "Veterinary Services for Livestock" [2]=> string(27) "Pharmaceutical Preparations" [3]=> string(42) "In Vitro and In Vivo Diagnostic Substances" } ["employee_count"]=> int(710) ["article_count"]=> int(644) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(66) "IDEXX Laboratories to Release 2024 First Quarter Financial Results" ["snippet_en"]=> string(233) "WESTBROOK, Maine, April 04, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens." ["url"]=> string(90) "https://es-us.finanzas.yahoo.com/news/idexx-laboratories-release-2024-first-203000755.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/05f95f58-f430-4b50-a78f-c08f08e16130" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-04-04" ["categories"]=> array(3) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(14) "Product Launch" } } [1]=> array(7) { ["title_en"]=> string(63) "VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript" ["snippet_en"]=> string(290) "VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript March 26, 2024 VolitionRx Limited isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and thank you for standing by." ["url"]=> string(77) "https://finance.yahoo.com/news/volitionrx-limited-amex-vnrx-q4-163122822.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/452ebebf-b2b3-4060-a1e8-c8e17f81a58e" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-03-27" ["categories"]=> array(3) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(15) "Deals & Tenders" [2]=> string(13) "Collaboration" } } [2]=> array(7) { ["title_en"]=> string(56) "IDEXX (IDXX) Q4 Earnings Surpass Estimates, Margins Fall" ["snippet_en"]=> string(92) "Across testing modalities, IDEXX (IDXX) achieves strong global growth in the fourth quarter." ["url"]=> string(76) "https://finance.yahoo.com/news/idexx-idxx-q4-earnings-surpass-153700324.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/501a77ec-40e7-4519-b7de-bbac31936f0e" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-02-05" ["categories"]=> array(2) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(31) "Financial Update/Profit Warning" } } [3]=> array(7) { ["title_en"]=> string(65) "IDEXX Laboratories (IDXX) to Release Quarterly Earnings on Monday" ["snippet_en"]=> string(204) "IDEXX Laboratories (NASDAQ:IDXX) will be releasing earnings before the market opens on Monday, February 5, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=259264)" ["url"]=> string(79) "https://www.marketbeat.com/instant-alerts/nasdaq-idxx-earnings-date-2024-01-29/" ["image_url"]=> NULL ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-29" ["categories"]=> array(4) { [0]=> string(15) "Market Movement" [1]=> string(5) "Event" [2]=> string(24) "Quarterly/Annual Figures" [3]=> string(14) "Product Launch" } } [4]=> array(7) { ["title_en"]=> string(48) "New York: positive result for IDEXX Laboratories" ["snippet_en"]=> string(148) "Marked increase for the world leader in the development of laboratory services and tests for animals, which makes a profit of 1.93% on the values..." ["url"]=> string(126) "https://finanza.lastampa.it/News/2024/01/09/new-york-risultato-positivo-per-idexx-laboratories/MTkxXzIwMjQtMDEtMDlfVExCLUFVVE8" ["image_url"]=> string(78) "https://images.businessradar.com/articles/1fdaeabb-1f4e-4f94-807b-0ff6b72b7e03" ["source"]=> string(11) "lastampa.it" ["publication_date"]=> string(10) "2023-12-04" ["categories"]=> array(4) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(18) "Ecological Impacts" [3]=> string(5) "R & D" } } [5]=> array(7) { ["title_en"]=> string(66) "Idexx (IDXX) Up 11.1% Since Last Earnings Report: Can It Continue?" ["snippet_en"]=> string(123) "Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues." ["url"]=> string(67) "https://finance.yahoo.com/news/idexx-idxx-11-1-since-163159329.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/efa8a5e6-8bd8-4fab-b7fb-f0a976e9d13e" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-12-01" ["categories"]=> array(2) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(12) "Stock Market" } } [6]=> array(7) { ["title_en"]=> string(66) "Idexx (IDXX) Up 11.1% Since Last Earnings Report: Can It Continue?" ["snippet_en"]=> string(158) "A month has gone by since the last earnings report for Idexx Laboratories (IDXX). Shares have added about 11.1% in that time frame, outperforming the S&P 500." ["url"]=> string(94) "https://www.nasdaq.com/articles/idexx-idxx-up-11.1-since-last-earnings-report:-can-it-continue" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-12-01" ["categories"]=> array(2) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(12) "Stock Market" } } [7]=> array(7) { ["title_en"]=> string(55) "IDEXX Laboratories (IDXX) Fell on Investors’ Concerns" ["snippet_en"]=> string(255) "Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The market rally that was driven by technology this year came to a halt in the third quarter." ["url"]=> string(87) "https://hk.finance.yahoo.com/news/idexx-laboratories-idxx-fell-investors-170025554.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a3643510-4bce-4d86-9855-511dd1522e43" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-11-11" ["categories"]=> array(6) { [0]=> string(18) "General Investment" [1]=> string(15) "Market Movement" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(24) "Quarterly/Annual Figures" [4]=> string(12) "Stock Market" [5]=> string(9) "Investors" } } [8]=> array(7) { ["title_en"]=> string(55) "IDEXX Laboratories (IDXX) Fell on Investors’ Concerns" ["snippet_en"]=> string(255) "Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The market rally that was driven by technology this year came to a halt in the third quarter." ["url"]=> string(84) "https://finance.yahoo.com/news/idexx-laboratories-idxx-fell-investors-170025554.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/0cb4817a-d90d-4134-9e8e-4cbc7b5de8f3" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-11-11" ["categories"]=> array(6) { [0]=> string(18) "General Investment" [1]=> string(15) "Market Movement" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(24) "Quarterly/Annual Figures" [4]=> string(12) "Stock Market" [5]=> string(9) "Investors" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(117) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(67) } [2]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(44) } [3]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(43) } [4]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(40) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(22) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(22) } [8]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(21) } [9]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(18) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(9) } [16]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(31) "Water and Wastewater Management" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(5) } } } 52dfe-us-idexx-laboratories-inc